e We compared PCR-electrospray ionization mass spectrometry (PCR-ESI/MS) to culture using sonicate fluid from 431 subjects with explanted knee (n ‫؍‬ 270) or hip (n ‫؍‬ 161) prostheses. Of these, 152 and 279 subjects had prosthetic joint infection (PJI) and aseptic failure, respectively. The sensitivities for detecting PJI were 77.6% for PCR-ESI/MS and 69.7% for culture (P ‫؍‬ 0.0105). The specificities were 93.5 and 99.3%, respectively (P ‫؍‬ 0.0002).
P
CR-electrospray ionization mass spectrometry (PCR-ESI/ MS) was first described as a diagnostic strategy for infectious diseases in 2005 (1, 2) and advanced in 2008 (3) . It has been used for broad-range bacterial and yeast detection in blood culture bottles and clinical samples (2, (4) (5) (6) (7) .
We previously showed that culture of fluid obtained by orthopedic implant vortexing/sonication is more sensitive than tissue culture for prosthetic joint infection (PJI) diagnosis (8) . The fact that culture-negative cases remained suggests that a molecular approach may be helpful. Herein, we tested sonicate fluid using the BAC detection assay (Abbott Laboratories, Abbott Park, IL), which detects/identifies 3,400 bacteria, four antimicrobial resistance genes (vanA, vanB, bla KPC , and mecA), and over 40 Candida species using multiplexed PCR followed by ESI/MS determination of the amplified product's base composition and software comparison to a commercial database.
(This study was presented in part at the 113th General Meeting of the American Society for Microbiology, 18 to 21 May 2013, Denver, CO.)
The study was approved by the Mayo Clinic Institutional Review Board. Mayo Clinic patients with hip (n ϭ 161) or knee (n ϭ 270) prostheses removed between April 2006 and May 2011 were studied. PJI was diagnosed using the Musculoskeletal Infection Society (MSIS) guidelines (9) ; for patients who did not have all data pieces required for classification by MSIS criteria, PJI diagnosis was made using Infectious Diseases Society of America (IDSA) guidelines (referred to herein as the "combined definition") (10) . Prosthesis failure not meeting criteria for PJI was defined as aseptic failure. Of these subjects, 152 and 279 had PJI and aseptic failure, respectively, with the groups being similar in age, gender, reason for primary arthroplasty, and joint site (Table 1) .
Removed prosthesis components were processed as previously described (8) and concentrated for culture (11) (12) (13) ; growth of Ն20 CFU/10 ml unconcentrated sonicate fluid was considered positive (13) . A 1-ml aliquot of frozen unconcentrated sonicate fluid was thawed, and DNA was extracted and assayed using BAC Detection 2.0 assay plates and the PLEX-ID PCR-ESI/MS instrument, as previously described (14) . A Q score (a rating between 0 and 1 which measures strength of the data for the identification of an organism) was generated, and results of Ն0.90 were reported. A level (a semiquantitative amount of amplicon detected as calculated using an internal calibrant) was also generated and reported in genome equivalents (GE)/well (1); failure of the calibrant to signal was interpreted as a failed report. Metzgar et al. have reported phylogeny covered by the assay and primers used, with limits of detection between 20 and 500 CFU/ml in blood (15) . Results of culture and PCR-ESI/MS using three definitions of PJI are shown in Table 2 . Using the combined definition, the sensitivities for detecting PJI were 77.6 and 69.7% for PCR-ESI/MS and culture, respectively (P ϭ 0.0105), and the specificities were 93.5% and 99.3%, respectively (P ϭ 0.0002), with analysis by the MSIS and the IDSA definitions of PJI yielding similar results (Table 2) . Among the 35 PJI subjects who had received antimicrobials in the 14 days preceding surgery, 85.7% (30) and 65.7% (23) were positive by PCR-ESI/MS and culture, respectively (P ϭ 0.0196). Among the 61 PJI subjects who had received antimicrobials in the 28 days preceding surgery, 85.7% (52) and 73.8% (45) were positive by PCR-ESI/MS and culture, respectively (P ϭ 0.0348).
Organisms detected in PJI subjects by culture (n ϭ 106) and PCR-ESI/MS (n ϭ 118) are shown in Table S1 in the supplemental material. Polymicrobial sonicate fluid culture results included two cases with five or more species, while PCR-ESI/MS detected a maximum of three species.
Eighteen subjects with aseptic failure had positive PCR-ESI/MS results, and 14 of those had no microbial detection by any other method. Nine of these had water/soil bacteria detected, two had unidentifiable bacteria detected, and two and one had Staphylococcus capitis and Lactococcus lactis detected, respectively (Table  3) . For the last three cases, infection was not suspected, no antimicrobials were given, and the subjects remained free from infection over 2 years of follow-up. Seven of 10 subjects with PCR-ESI/MS detection of water/soil organisms had samples collected within a one-month period and processed in succession (Table 3) , suggesting either processing or reagent contamination. Three subjects (one each with Streptococcus pseudopneumoniae, Klebsiella pneumoniae, and group B Streptococcus sp.) had the same organism detected using other molecular methods (Table 3 ) and previous culture-positive infections with the organism detected by PCR-ESI/MS. Two subjects with aseptic failure had positive sonicate fluid cultures (Ͼ100 CFU/plate), one with viridans group streptococci and another with Clostridium perfringens and Propionibacterium acnes (Table 3) .
There were no PJI cases caused by carbapenem-resistant Enterobacteriaceae. Three PJI cases yielded vancomycin-resistant Enterococcus faecium, with vanA being detected in all three. Of 42 cases with methicillin resistance detected in cultured staphylococci, 38 had mecA detected by PCR-ESI/MS, three did not have staphylococci (or mecA) detected by PCR-ESI/MS, and one had Staphylococcus caprae (but not mecA) detected by PCR-ESI/MS (with S. caprae detected by culture).
Of the 118 PJI cases that were positive by PCR-ESI/MS, 85 had microbiology concordant with culture, 17 were sonicate fluid culture negative (Table 4) , 10 had an additional organism(s) detected in sonicate fluid culture (Table 5) , four had an additional organism(s) detected by PCR-ESI/MS (Table 5) , and two had discordant microbiology (Table 6 ). Of the 106 sonicate fluid culturepositive PJI cases, five were not identified by PCR-ESI/MS (Table  4) . Ten PJI cases with no methicillin resistance detected in culture had mecA detected by PCR-ESI/MS (five had a level of Յ4, and three were culture-negative cases).
PCR-ESI/MS sensitivity (77.6%) for detecting PJI from sonicate fluid was equivalent to the sensitivity (77.1%) we recently reported with a genus-/group-specific rapid PCR panel assay targeting PJI bacteria (16) and was better than that of a 16S rRNA gene PCR assay, which had a sensitivity of 70.4% (17); both referenced studies used a set of samples similar to that studied herein (with the same subjects studied in some cases). PCR-ESI/MS was less affected than culture by prior antimicrobials; PCR-ESI/MS sensitivity (85.7%) among subjects receiving antimicrobial therapy within 14 or 28 days of surgery was equivalent to the sensitivity (87.9 and 86.2%, respectively) found with the PCR panel assay (16) . However, PCR-ESI/MS specificity (93.5%) was less than the specificity of the PCR panel assay (97.9%) (16) . Advantages of the PCR-ESI/MS assay include its multiplexed format, 0.04 ml sonicate fluid/PCR template DNA input (versus 2 ml using the previously described 16S rRNA [17] and panel [16] PCR assays), fast turnaround time (6.5 to 8.5 h versus 1 to 14 days for culture), and rapid detection of antimicrobial resistance markers. Other investigators have tested sonicate fluid using a commercial multiplex real-time PCR assay, Septifast (Roche Diagnostics, Basel, Switzer- a Only the first prosthesis removal surgery was studied; subjects undergoing only polyethylene liner exchange were excluded. Patient characteristics were summarized as frequencies and percentages or median (minimum, maximum) and compared using the chi-square test or Wilcoxon rank sum test as appropriate (SAS version 9.2; SAS Inc., Cary, NC). All tests were two sided, and P values less than 0.05 were considered statistically significant. Intraoperatively, tissues were collected for culture and histopathology and processed as previously described (16) . Neg NA a ND, not done; Neg, negative; NG, no growth; MS, methicillin sensitive; MR, methicillin resistant; CNS, coagulase-negative staphylococci; ENT, Enterobacteriaceae assay (includes E. coli and S. marcescens); TMP/SFX, trimethoprimsulfamethoxazole; Prop. sp., Propionibacterium/Actinomyces sp. assay (includes P. acnes); Coryne. sp., Corynebacterium sp. assay (includes C. simulans); NA, not applicable. b Intraoperatively, tissues were collected for culture and histopathology and processed as previously described (16) . c Synovial fluid samples with volumes of Ͼ1 ml were inoculated into a Bactec Peds Plus/F bottle and incubated on a Bactec 9240 instrument (BD Diagnostic Systems, Sparks, MD) for 5 days (23) . Synovial fluid samples with volumes of Յ1 ml were cultured as previously described (16) . Any growth was classified and considered positive. d PCR used primers which amplify the V3-V4 hypervariable region of the 16S rRNA gene with Roche LightCycler SYBR green detection followed by sequencing of amplified product, with RipSeq software to analyze mixed sequences (17) . e A 10-assay panel of real-time FRET probe PCR assays (using Roche LightCycler) which detects multiple bacterial pathogens typically considered causes of PJI (staphylococci, streptococci, Enterobacteriaceae, anaerobic Gram-positive cocci, Enterococcus/Granulicatella/Abiotrophia spp., Propionibacterium/Actinomyces spp., Pseudomonas aeruginosa, Corynebacterium spp., and Bacteroides fragilis group) and mecA using a variety of gene targets (16, 24, 25) . f Susceptibilities were not determined. Intraoperatively, tissues were collected for culture and histopathology and processed as previously described (16) .
c Synovial fluids with volumes of Ͼ1 ml were inoculated into a Bactec Peds Plus/F bottle and incubated on a Bactec 9240 instrument (BD Diagnostic Systems, Sparks, MD) for 5 days (23) . Synovial fluids with volumes Յ1 ml were cultured as previously described (16) . Any growth was classified and considered positive.
d PCR used primers which amplify the V3-V4 hypervariable region of the 16S rRNA gene with Roche LightCycler SYBR green detection followed by sequencing of the amplified product, with RipSeq software to analyze mixed sequences (17) .
e A 10-assay panel of real-time FRET probe PCR assays (using Roche LightCycler) which detects multiple bacterial pathogens typically considered causes of PJI (staphylococci, streptococci, Enterobacteriaceae, anaerobic Gram-positive cocci, Enterococcus/Granulicatella/Abiotrophia spp., Propionibacterium/Actinomyces spp., Pseudomonas aeruginosa, Corynebacterium spp., and Bacteroides fragilis group) and mecA using a variety of gene targets (16, 24, 25) .
land), which does not target anaerobes (18, 19) ; the PCR-ESI/MS assay studied detected nine anaerobic bacteria (see Table S1 in the supplemental material).
Despite the increased sensitivity of PCR-ESI/MS compared to culture, there remained 34 PCR-ESI/MS-negative PJI cases; 29 had negative sonicate fluid cultures. Using a similar PCR-ESI/MS technique on synovial fluid specimens, Jacovides et al. reported organism detection in four culture-negative PJI cases and in 88% of cases with presumed noninfectious failure (20) . Differences between the study by Jacovides et al. and ours may be explained by differences in specimen type or software and hardware differences of the PCR/ESI-MS platform. The platform used by Jacovides et al. was an older version designed as a research tool, with no specific cutoff or reporting criteria defined within the software, whereas the system we evaluated was designed for clinical use, using a more stringent analysis.
In summary, PCR-ESI/MS is more sensitive but less specific than culture for PJI diagnosis when performed on material dislodged from the surfaces of explanted orthopedic prostheses and may be a useful tool for the rapid detection of PJI and/or as an adjunctive method for select cases of arthroplasty failure. a Intraoperatively, tissues were collected for culture and histopathology and processed as previously described (16) . b Synovial fluids with volumes of Ͼ1 ml were inoculated into a Bactec Peds Plus/F bottle and incubated in a Bactec 9240 instrument (BD Diagnostic Systems, Sparks, MD) for 5 days (23) . Synovial fluid samples with volumes of Յ1 ml were cultured as previously described (16) . Any growth was classified and considered positive. NG, no growth. c PCR used primers which amplify the V3-V4 hypervariable region of the 16S rRNA gene with Roche LightCycler SYBR green detection followed by sequencing of amplified product, with RipSeq software to analyze mixed sequences (17) . d A 10-assay panel of real-time FRET probe PCR assays (using Roche LightCycler) which detects multiple bacterial pathogens typically considered causes of PJI (staphylococci, streptococci, Enterobacteriaceae, anaerobic Gram-positive cocci, Enterococcus/Granulicatella/Abiotrophia sp., Propionibacterium/Actinomyces sp., Pseudomonas aeruginosa, Corynebacterium sp., and Bacteroides fragilis group) and mecA using a variety of gene targets (16, 24, 25) .
